MDT - Medtronic plc

NYSE - Nasdaq Real Time Price. Currency in USD
88.27
-0.02 (-0.02%)
As of 1:04PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close88.29
Open88.29
Bid88.26 x 1300
Ask88.27 x 800
Day's Range88.07 - 88.77
52 Week Range76.41 - 88.83
Volume2,468,900
Avg. Volume4,637,198
Market Cap119.315B
Beta0.75
PE Ratio (TTM)38.89
EPS (TTM)2.27
Earnings DateAug 21, 2018
Forward Dividend & Yield2.00 (2.26%)
Ex-Dividend Date2018-07-05
1y Target Est94.60
Trade prices are not sourced from all markets
  • Reuters5 hours ago

    Israel grants $33 mln to GE, Medtronic, Change Healthcare to boost R&D

    Three multinational companies have received an Israeli government grant of 120 million shekels ($33 million) aimed at boosting the presence of large companies and establishing Israel as a hub in biotechnology and medicine. The grants are part of a new programme to boost the field of digital health, inject new intellectual property in Israel, which is expected to generate significant future tax income, and establish a long-term presence for multinational firms. The companies chosen to participate in the programme are medical device firm Medtronic, GE Healthcare, a unit of General Electric, and Change Healthcare, a supplier of digital health solutions.

  • ACCESSWIRE6 hours ago

    Free Technical Research on Medtronic and Three More Medical Equipment Equities

    On Tuesday, July 17, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Six out of nine sectors ended Tuesday's trading session in bullish territories. Taking into consideration yesterday's market sentiment, WallStEquities.com assessed the following Medical Appliances & Equipment equities this morning: AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX), Masimo Corp. (NASDAQ: MASI), Medtronic PLC (NYSE: MDT), and MiMedx Group Inc. (NASDAQ: MDXG).

  • Moody's20 hours ago

    MedPlast Holdings, Inc. -- Moody's assigns B2 CFR to MedPlast Holdings, Inc.

    Rating Action: Moody's assigns B2 CFR to MedPlast Holdings, Inc. New York, July 17, 2018 -- Moody's Investors Service ("Moody's) assigned a B2 Corporate Family Rating (CFR) and B2-PD Probability of Default Rating to MedPlast Holdings, Inc. ("MedPlast"). Moody's also assigned a B1 rating to the company's first lien credit facilities comprised of a $70 million revolving credit facility and a $500 million first lien term loan and a Caa1 rating to the company's $225 million second lien term loan.

  • Is Intuitive Surgical, Inc. a Buy?
    Motley Fool5 days ago

    Is Intuitive Surgical, Inc. a Buy?

    The robotic surgical systems leader is red-hot right now. But will the stock's momentum fade?

  • Medtronic Wins Expanded Indication for SelectSecure(TM) MRI SureScan(TM) Pacing Lead for His Bundle Site Stimulation
    GlobeNewswire6 days ago

    Medtronic Wins Expanded Indication for SelectSecure(TM) MRI SureScan(TM) Pacing Lead for His Bundle Site Stimulation

    July 12, 2018 - Medtronic plc (MDT) today announced U.S. Food and Drug Administration (FDA) labeling expansion for the Medtronic SelectSecure(TM) MRI SureScan(TM) Model 3830 cardiac pacing lead to include stimulation of the bundle of His. The steroid-eluting, bipolar SelectSecure SureScan MRI model 3830 lead (lengths of 59, 69 and 74 cm) is attached to a single or dual chamber pacemaker, and approved for pacing and sensing in the atrium, right ventricle, or at the bundle of His as an alternative to right ventricular pacing. Lead placement at or near the bundle of His can be facilitated by the Medtronic C315HIS delivery catheter.

  • The Wall Street Journal7 days ago

    [$$] Medtronic Gets FDA Approval for Less-Invasive Heart Pump Implant Procedure

    Medtronic said it received FDA approval for a less-invasive implant approach of its HVAD System, a left ventricular assist device for patients with advanced heart failure.

  • Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure
    GlobeNewswire7 days ago

    Medtronic Receives FDA Approval for Less-Invasive Heart Pump Implant Procedure

    July 11, 2018 - Medtronic plc (MDT) has received United States Food and Drug Administration (FDA) approval for a less-invasive implant approach of its HVAD(TM) System, a left ventricular assist device (LVAD) for patients with advanced heart failure. The HVAD System is the smallest commercially available LVAD, and the only LVAD approved in the U.S. for implant via thoracotomy, a small lateral, surgical incision between the patient`s ribs on the left side of the chest.

  • Medtronic Launches New Stealthstation™ Technology In Canada For Neurosurgery, Spinal, And Ear Nose And Throat Procedures
    CNW Group7 days ago

    Medtronic Launches New Stealthstation™ Technology In Canada For Neurosurgery, Spinal, And Ear Nose And Throat Procedures

    BRAMPTON, ON, July 11, 2018 /CNW/ - Medtronic of Canada Ltd., a subsidiary of Medtronic plc (MDT), today announced the StealthStation™ S8 and the StealthStation™ ENT (Ear, Nose and Throat) surgical navigation systems are now licensed for sale in Canada . Surgeons use surgical navigation systems to help with precisely locating anatomical structures and instruments in either open or minimally invasive procedures on rigid parts of the body like the skull and vertebra, as well as sinus cavities. Both platforms are now commercially available in Canada .

  • First-Year Results from Medtronic and UnitedHealthcare Value-Based Relationship Demonstrate Cost-Savings and Reduced Hospital Admissions
    GlobeNewswire8 days ago

    First-Year Results from Medtronic and UnitedHealthcare Value-Based Relationship Demonstrate Cost-Savings and Reduced Hospital Admissions

    July 10, 2018 - Medtronic plc (MDT) and UnitedHealthcare today announced first year results from an innovative value-based relationship focused on delivering patient-centered solutions that improve health outcomes while reducing soaring healthcare costs related to managing diabetes. Results from an analysis of over 6,000 members with diabetes on Medtronic MiniMed(TM) 630G and previous generation insulin pumps demonstrated 27 percent fewer preventable hospital admissions compared to plan participants who are on multiple daily injections of insulin (MDI).

  • 2 Stocks That Turned $1,000 Into More Than $8,000 This Year
    Motley Fool9 days ago

    2 Stocks That Turned $1,000 Into More Than $8,000 This Year

    Just because risky stocks become winners doesn't mean you should be casting your lot with them.

  • TheStreet.com9 days ago

    Evercore Likes Becton Dickinson, Medtronic Ahead of Quarterly Results

    Evercore ISI analyst Vijay Kumar has named Becton, Dickinson and Co. The three months ended June 30, BD's third fiscal quarter for 2018, is the "first clean [quarter] without any adjustments for US dispensing change / flu noise," Kumar wrote in a note on Monday, July 9. Franklin Lakes, N.J.-based BD is scheduled to release results on Aug. 2.

  • Medtronic (MDT) Rides on Innovation, Rising Costs a Woe
    Zacks9 days ago

    Medtronic (MDT) Rides on Innovation, Rising Costs a Woe

    Medtronic (MDT) continues to meaningfully accelerate all its three fundamental growth strategies, namely therapy innovation, globalization and economic value.

  • Top Stocks Set to Disrupt the Diabetes Market
    Motley Fool12 days ago

    Top Stocks Set to Disrupt the Diabetes Market

    Revolutionary new drugs and medical devices could make these companies smart additions to your portfolio.

  • Is Medtronic (MDT) a Great Stock for Value Investors?
    Zacks12 days ago

    Is Medtronic (MDT) a Great Stock for Value Investors?

    Let's see if Medtronic (MDT) stock is a good choice for value-oriented investors right now from multiple angles.

  • Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day
    Zacks19 days ago

    Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day

    Polaris, 58.com, BlackRock, Intuitive Surgical, Medtronic and NuVasive as Zacks Bull and Bear of the Day

  • ETF Trends19 days ago

    Medical Device ETFs Still Look Healthy

    Medical device stocks and the related ETFs are among the brightest spots in the broader healthcare sector this year. iShares U.S. Medical Devices ETF (NYSEArca: IHI), the largest dedicated medical devices ...

  • GlobeNewswire19 days ago

    Market Trends Toward New Normal in Applied Optoelectronics, Integra LifeSciences, Medtronic, Workhorse Group, Platform Specialty Products, and Career Education — Emerging Consolidated Expectations, Analyst Ratings

    NEW YORK, June 29, 2018-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Applied ...

  • 3 Stocks to Tap the Minimally-Invasive Surgery Market Boom
    InvestorPlace20 days ago

    3 Stocks to Tap the Minimally-Invasive Surgery Market Boom

    The United States has hit rough waters of late. Rising trade war tensions between the United States and China are showing no signs of abatement. The issue has escalated to a point where imposition of tariffs and retaliatory tariffs may go up to $450 billion on both the sides.

  • Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers
    GlobeNewswire20 days ago

    Medtronic Launches the MiniMed(TM) 670G System Performance Guarantee for Payers and Employers

    DUBLIN- June 28, 2018 - Medtronic plc (MDT), the global leader in medical technology, today announced the launch of the MiniMed(TM) 670G Performance Guarantee Program - an outcomes-based offering for payers and employers designed to mitigate costs for diabetes-related complications. With this Guarantee, Medtronic will provide flat-fee reimbursements up to $25,000 per pump over 4 years for qualifying diabetes-related inpatient hospitalization and emergency room admissions for eligible in-network patients in the United States. "This new program demonstrates the strong confidence we have in our ability to deliver improved clinical outcomes with our MiniMed670G system and our commitment to value-based healthcare that not only improves outcomes but drives down the enormous burden of diabetes-related healthcare costs," said Alejandro Galindo, president of the Advanced Insulin Management division within the Diabetes Group at Medtronic.

  • MDT’s Diabetes Business Could Significantly Boost Its Revenue
    Market Realist20 days ago

    MDT’s Diabetes Business Could Significantly Boost Its Revenue

    In fiscal Q4 2018, Medtronic’s (MDT) Diabetes segment generated revenue of $645 million compared to $512 million in fiscal 2017, which reflected a ~26% rise YoY (year-over-year).

  • 3 Stocks to Tap the Minimally-Invasive Surgery Market Boom
    Zacks20 days ago

    3 Stocks to Tap the Minimally-Invasive Surgery Market Boom

    Consider these three stocks in the rapidly-growing minimally-invasive surgical device market.

  • An In-Depth Look at MDT’s Restorative Therapies Growth Trend
    Market Realist20 days ago

    An In-Depth Look at MDT’s Restorative Therapies Growth Trend

    In fiscal Q4 2018, Medtronic’s (MDT) restorative spine therapies business generated revenue of $699 million compared to $676 million in fiscal Q4 2017, a rise of ~3% YoY (year-over-year).

  • 3 Top Healthcare Stocks to Buy Right Now
    Motley Fool20 days ago

    3 Top Healthcare Stocks to Buy Right Now

    A cancer-drug developer, generic-drug manufacturer, and medical device kingpin may be just what the doctor ordered.

  • How MDT’s Restorative Therapies Group Performed in Fiscal 2018
    Market Realist20 days ago

    How MDT’s Restorative Therapies Group Performed in Fiscal 2018

    In fiscal Q4 2018, Medtronic’s (MDT) Restorative Therapies Group segment reported revenue of $2.1 billion compared to $1.95 billion in fiscal Q4 2017, which reflected a ~9% YoY (year-over-year) rise.

  • Morningstar20 days ago

    Healthcare: Drug Pricing Concerns Weigh on Valuations, Creating Opportunities

    Innovation, consolidation, and a mixed regulatory picture for healthcare stocks in the second quarter.